Early experience with simulect (basiliximab) induction in living donor renal allografting in India

Author： Siwach V. Dhanda R. Aggarwal B. Singh B. Jain P.K. Sarin P.K.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.35, Iss.1, 2003-02, pp. : 196-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An early experience with Simulect (basiliximab): an IL-2 receptor antibody

By Hinduja A. Abraham G. Eapen G. Shroff S. Rao R. Kuruvilla S.

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1739-1740

Elsevier

Access to resources Recommend Favorite

Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors

By Mulloy L.L. Wright F. Hall M.L. Moore M.

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1210-1213

Elsevier

Access to resources Recommend Favorite

A single center experience with basiliximab induction therapy in renal transplantation

By Henry M.L. Pelletier R.P. Elkhammas E.A. Bumgardner G.L. Ferguson R.M.

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3178-3179

Elsevier

Access to resources Recommend Favorite

Experience with basiliximab in pediatric renal transplantation

By Vilalta R. Vila A. Nieto J. Espanol T. Caragol I. Calls L.

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 100-101

Elsevier

Access to resources Recommend Favorite

Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors

By Langer R.M. Hong D.M. Katz S.M. Van Buren C.T.

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3162-3164

Elsevier

Access to resources Recommend Favorite